Germline mutations of BRCA1/2 are known to be associated with an increased risk of the development of ovarian cancer and breast cancer [146,147,148] and are also found in PCs at a frequency of about 4–7% [149,150,151,152,153]. This evidence concerns the gene BRCA1 and ovarian cancer.